These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12893105)

  • 1. HIV disease progression: depression, stress, and possible mechanisms.
    Leserman J
    Biol Psychiatry; 2003 Aug; 54(3):295-306. PubMed ID: 12893105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of depression, stress, and trauma in HIV disease progression.
    Leserman J
    Psychosom Med; 2008 Jun; 70(5):539-45. PubMed ID: 18519880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Workshop report: The effects of psychological variables on the progression of HIV-1 disease.
    Kopnisky KL; Stoff DM; Rausch DM
    Brain Behav Immun; 2004 May; 18(3):246-61. PubMed ID: 15050652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychoneuroimmunology and HIV infection.
    Gorman JM; Kertzner R
    J Neuropsychiatry Clin Neurosci; 1990; 2(3):241-52. PubMed ID: 2136081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial-immune relationships in HIV disease.
    Cruess DG; Leserman J; Petitto JM; Golden RN; Szuba MP; Morrison MF; Evans DL
    Semin Clin Neuropsychiatry; 2001 Oct; 6(4):241-51. PubMed ID: 11607920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping pathways from stress to cancer progression.
    Ross K
    J Natl Cancer Inst; 2008 Jul; 100(13):914-5, 917. PubMed ID: 18577741
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of stressful life events, coping, and cortisol on HIV infection.
    Leserman J
    CNS Spectr; 2003 Jan; 8(1):25-30. PubMed ID: 12627047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How trauma, recent stressful events, and PTSD affect functional health status and health utilization in HIV-infected patients in the south.
    Leserman J; Whetten K; Lowe K; Stangl D; Swartz MS; Thielman NM
    Psychosom Med; 2005; 67(3):500-7. PubMed ID: 15911916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression and HIV infection: impact on immune function and disease progression.
    Cruess DG; Petitto JM; Leserman J; Douglas SD; Gettes DR; Ten Have TR; Evans DL
    CNS Spectr; 2003 Jan; 8(1):52-8. PubMed ID: 12627049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse psychosocial factors predict poorer prognosis in HIV disease: a meta-analytic review of prospective investigations.
    Chida Y; Vedhara K
    Brain Behav Immun; 2009 May; 23(4):434-45. PubMed ID: 19486650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological distress and physical pain appear to have no short-term adverse impact on plasma HIV-1 RNA levels in patients on successful HAART.
    Nettles RE; Keiffer TL; Cofrancesco J; Gallant JE; Quinn T; Jackson B; Flexner C; Carson KA; Wu AW; Siliciano RF
    HIV Clin Trials; 2005; 6(5):262-71. PubMed ID: 16425464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychoneuroimmunology: a basis for HIV treatment.
    Leiphart JM
    Focus; 1997 Feb; 12(3):1-4. PubMed ID: 11364257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of depression on the progression of HIV: direct and indirect effects.
    Schuster R; Bornovalova M; Hunt E
    Behav Modif; 2012 Mar; 36(2):123-45. PubMed ID: 22089635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune correlates of stress and depression.
    Evans DL; Leserman J; Pedersen CA; Golden RN; Lewis MH; Folds JA; Ozer H
    Psychopharmacol Bull; 1989; 25(3):319-24. PubMed ID: 2697005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPA and immune axes in stress: involvement of the serotonergic system.
    Leonard BE
    Neuroimmunomodulation; 2006; 13(5-6):268-76. PubMed ID: 17709948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression and distress in older HIV+ adults.
    Rabkin JG; McElhiney M
    GMHC Treat Issues; 2007; 21(2):3-5. PubMed ID: 18411475
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality of life and immune activation in patients with HIV-infection.
    Schroecksnadel K; Sarcletti M; Winkler C; Mumelter B; Weiss G; Fuchs D; Kemmler G; Zangerle R
    Brain Behav Immun; 2008 Aug; 22(6):881-9. PubMed ID: 18261883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P and neurokinin-1 receptor modulation of HIV.
    Ho WZ; Douglas SD
    J Neuroimmunol; 2004 Dec; 157(1-2):48-55. PubMed ID: 15579279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychology, immunology, and HIV.
    Nott KH; Vedhara K; Spickett GP
    Psychoneuroendocrinology; 1995; 20(5):451-74. PubMed ID: 7675931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress reduction and HIV disease: a review of intervention studies using a psychoneuroimmunology framework.
    Robinson FP; Mathews HL; Witek-Janusek L
    J Assoc Nurses AIDS Care; 2000; 11(2):87-96. PubMed ID: 10752051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.